ATOSSA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
ATOSSA THERAPEUTICS, INC. (ATOS) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $0 as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-08-07
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $120.00.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $445.92K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $120.00 10-K · filed 2026-03-25 | |
| 2025-09-30 | $445.92K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $343.10K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $9.48K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $657.81K 10-K · filed 2025-03-25 | |
| 2024-09-30 | $6.09M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.39M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $8.35M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $554.52K 10-Q · filed 2024-11-12 | |
| 2023-09-30 | $117.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $3.25M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $44.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $0.00 10-Q · filed 2023-05-15 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $183.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $1.01M 10-Q · filed 2022-05-09 | |
| 2021-09-30 | $11.70M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $44.15M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $3.87M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $0.00 10-K · filed 2021-03-31 | |
| 2020-09-30 | $5.63M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $15.21M 10-Q · filed 2020-08-13 | |
| 2019-12-31 | $651.00K 10-Q · filed 2020-11-13 | |
| 2018-03-31 | $520.00 10-Q · filed 2018-05-14 | |
| 2017-09-30 | $102.68K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $51.51K 10-Q · filed 2017-08-14 | |
| 2016-09-30 | $6.45M 10-Q/A · filed 2017-03-21 | |
| 2016-06-30 | $47.24K 10-Q/A · filed 2017-03-21 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-14 | |
| 2015-09-30 | $500.00 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $39.40K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $884.65K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $344.00K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $117.27K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $561.65K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $107.80K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $282.06K 10-K · filed 2015-03-30 | $3.66M 10-K · filed 2014-03-27 |
| 2013-09-30 | $3.60M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $3.73M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $2.24M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $1.15M 10-K · filed 2014-03-27 | |
| 2012-09-30 | $389.05K 10-Q/A · filed 2013-01-22 | |
| 2011-12-31 | $329.05K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |